EDN1 and ovarian carcinoma: ET1 has been shown not only to increase the expression of various MMPs but also to reduce the expression of TIMP 1 and 2 (TIMP = tissue inhibitors of MMP1), leading to rapid ECM degradation and subsequently to increased metastasis and invasion in ovarian cancer and Kaposi's sarcoma [68,69].